Cargando…
Understanding the benefit of metformin use in cancer treatment
Biguanides have been developed for the treatment of hyperglycemia and type 2 diabetes. Recently, metformin, the most widely prescribed biguanide, has emerged as a potential anticancer agent. Epidemiological, preclinical and clinical evidence supports the use of metformin as a cancer therapeutic. The...
Autores principales: | Dowling, Ryan JO, Goodwin, Pamela J, Stambolic, Vuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224599/ https://www.ncbi.nlm.nih.gov/pubmed/21470407 http://dx.doi.org/10.1186/1741-7015-9-33 |
Ejemplares similares
-
Metformin and Exercise in Cancer: Better Together
por: Stambolic, Vuk, et al.
Publicado: (2019) -
Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study
por: Dowling, Ryan JO, et al.
Publicado: (2015) -
Biomarkers in anal cancer: from biological understanding to stratified treatment
por: Jones, Christopher M, et al.
Publicado: (2017) -
Understanding the cancer stem cell
por: Bomken, S, et al.
Publicado: (2010) -
Which biomarker predicts benefit from EGFR-TKI treatment for patients with lung cancer?
por: Uramoto, H, et al.
Publicado: (2007)